Alpha Cognition Total Current Liabilities 2020-2024 | ACOG
Alpha Cognition total current liabilities from 2020 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Alpha Cognition Annual Total Current Liabilities
(Millions of US $) |
| 2023 |
$3 |
| 2022 |
$4 |
| 2021 |
$2 |
| 2020 |
$4 |
| 2019 |
$0 |
Alpha Cognition Quarterly Total Current Liabilities
(Millions of US $) |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$3 |
| 2023-09-30 |
$3 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$2 |
| 2021-09-30 |
$1 |
| 2021-06-30 |
$1 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$4 |
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
